Table 1.
Demographic and clinical measures for the sertraline and placebo groups.
| SERT (n=110) | PBO (n= 112) | Group comparison | ||||
|---|---|---|---|---|---|---|
| Frequency | Percent | Frequency | Percent | Statistic | P-value | |
| Sex (female/male) | 80/30 | 73%/ 27% | 68/44 | 61%/ 39% | X2(1)=3.6 | p=0.06 |
| Employment (yes/no) | 61/49 | 55%/ 45% | 68/44 | 61%/ 39% | X2(1)=.63 | p=0.43 |
| Marital status (yes/no) | 19/91 | 17%/ 83% | 28/84 | 25%/ 75% | X2(1)=1.99 | p=0.16 |
| Race (Caucasian, non-Caucasian) | 71/39 | 65%/ 35% | 78/34 | 70%/ 30% | X2(1)=.65 | p=0.42 |
| Chronicity (chronic/non-chronic) | 55/55 | 50%/ 50% | 57/55 | 51%/ 49% | X2(1)=.02 | p=0.89 |
| Mean | SD | Mean | SD | |||
| Age | 36.84 | 13.17 | 36.94 | 12.35 | t(220)= −.06 | p=0.95 |
| Education (years) | 14.96 | 2.68 | 15.29 | 2.74 | t(220)= −.93 | p=0.35 |
| HRSD baseline | 18.59 | 4.36 | 18.91 | 4.17 | t(220)= −.56 | p=0.58 |
| SHAPS | 33.65 | 5.17 | 32.75 | 5.64 | t(220)= 1.25 | p=0.21 |
| MASQ-AA | 17.82 | 5.89 | 17.01 | 5.22 | t(220)= 1.08 | p=0.28 |
HRSD = Hamilton Rating Scale for Depression; SHAPS= Snaith–Hamilton Pleasure Scale (the four response categories were coded as separate scores (ranging from 0 to 3); MASQ-AA= Mood and Anxiety Symptom Questionnaire Anxious Arousal Scale